EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application lansoprazole delayed-release orally disintegrating tablets, 15 mg and 30 mg.
According to published reports, U.S. District Judge Matthew Kacsmaryk on Friday suspended the Food and Drug Administration’s longtime approval of key abortion pill mifepristone, though he gave the government a week to appeal his decision.
The U.S. Department of Health and Human Services plans to end the federal COVID-19 Public Health Emergency on May 11, but ensuring access to novel vaccines to meet future needs continues to be imperative.
Today, the U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), is finalizing a rule to put people with Medicare first and put strong protections in place so that Medicare Advantage (MA) works for them.
Registration is now open for McKesson ideaShare in Las Vegas from June 22–25, 2023. McKesson ideaShare is the nation’s premier community pharmacy annual education and networking event, hosted by McKesson, Health Mart, and Health Mart Atlas.
Hy-Vee, Inc. announced the grand opening of its first Hy-Vee Health infusion clinic, located at 7300 Westown Parkway, Suite 320, in West Des Moines, Iowa.
A recent study assessing the value of a specialty pharmacy order review program revealed the program prevented waste for those who received injectable fertility medications, helping to positively impact patient adherence and outcomes.
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application nitrofurantoin capsules USP (Monohydrate/Macrocrystals) 100mg.
and the importance of supporting pharmacy data interoperability so that more pharmacies have even greater abilities to provide expanded clinical services to the patients who rely on them.
COLUMBUS, Ohio – Gifthealth, a leading pharmaceutical software company built to streamline the Rx experience through intelligent scripts, secured a growth investment from Eir Partners, a Miami-based private equity firm that invests in high-growth healthcare companies.
Eyad Farah, president of Health Mart and Health Mart Atlas, has left McKesson Corp. to take a role at Orsini Specialty Pharmacy.
Advanced therapies designed to target rosacea’s disease processes combined with treatment plans tailored to each individual’s specific case have made it easier than ever for patients to achieve clear skin.
Transaction Data Systems (TDS), the leader in pharmacy software solutions, is set to take patient-centric care to the next level with the promotions of Alex Miguel to Chief Operating Officer and Grant Chapin to Senior Vice President of Mergers and Acquisitions, and the recent appointments of Tom Mul
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application pregabalin capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg.
Dr. Reddy’s Laboratories announced the launch, in the U.S. market, of lenalidomide capsules, a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration. With this volume-limited launch, Dr.
PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of aminocaproic acid oral solution, USP to its current portfolio. Aminocaproic acid oral solution is useful in enhancing hemostasis when fibrinolysis contributes to bleeding.
